Morphologic and Immunocytochemical Features of High-Grade Serous Carcinoma of Ovary in Ascitic Fluid Effusion and Fine-Needle Aspiration Cytology

被引:12
作者
Bansal, Akriti [1 ]
Srinivasan, Radhika [1 ]
Rohilla, Manish [1 ]
Sundaram, Archana [1 ]
Rai, Bhavana [2 ]
Rajwanshi, Arvind [1 ]
Suri, Vanita [3 ]
Saha, Subhash C. [3 ]
Gupta, Nalini [1 ]
Gupta, Parikshaa [1 ]
Dey, Pranab [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Cytol & Gynaecol Pathol, Chandigarh, India
[2] Postgrad Inst Med Educ & Res, Dept Radiotherapy & Oncol, Chandigarh, India
[3] Postgrad Inst Med Educ & Res, Dept Obstet & Gynaecol, Chandigarh, India
关键词
High-grade serous carcinoma ovary; Ascitic fluid; Fine-needle aspiration; Ovarian carcinoma; Neoadjuvant chemotherapy; NACT; NEOADJUVANT CHEMOTHERAPY; CANCER; PAX8; EXPRESSION; WT1; TUBOOVARIAN; PERITONEAL; MARKER; IMMUNOHISTOCHEMISTRY; ADENOCARCINOMA;
D O I
10.1093/ajcp/aqaa028
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objectives: High-grade serous carcinoma (HGSC) is the most common ovarian malignancy. The role of cytopathology in obtaining tissue diagnosis before institution of neoadjuvant chemotherapy (NACT) was evaluated. Methods: All histopathology-proven HGSC specimens between 2015 and 2018 with prior cytopathologic diagnosis by ascitic fluid evaluation or fine-needle aspiration (FNA) of ovarian mass were reviewed with cell block immunocytochemistry for CK7, CK20, PAX8, WT1, and p53. Results: Of 288 cases of HGSC, pre-NACT cytology diagnosis was established in 32% (93/288), with specific HGSC diagnoses made on ascitic fluid in 88% (82/93) and by ovarian mass FNA in 12% ( 11/93). The ascitic fluid showed moderatelhigh cellularity with papillary clusters in 76% (71/93) cases. Cell block immunocytochemistry showed tunior cells positive for CK7, PAX8, and WT1. p53 showed mutant or null-type positivity in 65% (33/51) and 33% (17/51) of cases, respectively, with 100% concordance with subsequent histopathologv specimens Poor/intermediate response to chemotherapy was shown in 75% of cases. Conclusions: Combined assessment of cytomorphology, cell block histomorphology, and ancillary immunohistochemical testing, including PAX8, WT1, and p53, allows for specific pre-NACT diagnoses of HGSC in ascitic fluid and ovarian FNA cytology. This practice allows for initiation of chemotherapy and diminution of disease burden prior to definitive surgical therapy.
引用
收藏
页码:103 / 114
页数:12
相关论文
共 29 条
  • [1] WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma
    Al-Hussaini, M
    Stockman, A
    Foster, H
    McCluggage, WG
    [J]. HISTOPATHOLOGY, 2004, 44 (02) : 109 - 115
  • [2] Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma
    Boehm, Steffen
    Faruqi, Asma
    Said, Ian
    Lockley, Michelle
    Brockbank, Elly
    Jeyarajah, Arjun
    Fitzpatrick, Amanda
    Ennis, Darren
    Dowe, Thomas
    Santos, Jennifer L.
    Cook, Linda S.
    Tinker, Anna V.
    Le, Nhu D.
    Gilks, C. Blake
    Singh, Naveena
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (22) : 2457 - U73
  • [3] Emerging roles for PAX8 in ovarian cancer and endosalpingeal development
    Bowen, Nathan J.
    Logani, Sanjay
    Dickerson, Erin B.
    Kapa, Laura B.
    Akhtar, Mariam
    Benigno, Benedict B.
    McDonald, John F.
    [J]. GYNECOLOGIC ONCOLOGY, 2007, 104 (02) : 331 - 337
  • [4] A comparison of p53 and WT1 immunohistochemical expression patterns in tubo-ovarian high-grade serous carcinoma before and after neoadjuvant chemotherapy
    Casey, Laura
    Kobel, Martin
    Ganesan, Raji
    Tam, Simone
    Prasad, Rajeev
    Bohm, Steffen
    Lockley, Michelle
    Jeyarajah, Arjun J.
    Brockbank, Eleanor
    Faruqi, Asma
    Gilks, C. Blake
    Singh, Naveena
    [J]. HISTOPATHOLOGY, 2017, 71 (05) : 736 - 742
  • [5] Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
    Cohen, Paul A.
    Powell, Aime
    Bohm, Steffen
    Gilks, C. Blake
    Stewart, Colin J. R.
    Meniawy, Tarek M.
    Bulsara, Max
    Avril, Stefanie
    Brockbank, Eleanor C.
    Bosse, Tjalling
    de Azevedo Focchi, Gustavo Rubino
    Ganesan, Raji
    Glasspool, Rosalind M.
    Howitt, Brooke E.
    Kim, Hyun-Soo
    Lee, Jung-Yun
    Le, Nhu D.
    Lockley, Michelle
    Manchanda, Ranjit
    Mandalia, Trupti
    McCluggage, W. Glenn
    McNeish, Iain
    Midha, Divya
    Srinivasan, Radhika
    Tan, Yun Yi
    van der Griend, Rachael
    Yunokawa, Mayu
    Zannoni, Gian F.
    Singh, Naveena
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 (02) : 441 - 448
  • [6] Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC)
    Ditzel, Helena M.
    Strickland, Kyle C.
    Meserve, Emily E.
    Stover, Elizabeth
    Konstantinopoulos, Panagiotis A.
    Matulonis, Ursula A.
    Muto, Michael G.
    Liu, Joyce F.
    Feltmate, Colleen
    Horowitz, Neil
    Berkowitz, Ross S.
    Gupta, Mamta
    Hecht, Jonathan L.
    Lin, Douglas I.
    Jochumsen, Kirsten M.
    Welch, William R.
    Hirsch, Michelle S.
    Quade, Bradley J.
    Lee, Kenneth R.
    Crum, Christopher P.
    Mutter, George L.
    Nucci, Marisa R.
    Howitt, Brooke E.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2019, 38 (03) : 230 - 240
  • [7] Mannose Binding Lectin Is Required for Alphavirus-Induced Arthritis/Myositis
    Gunn, Bronwyn M.
    Morrison, Thomas E.
    Whitmore, Alan C.
    Blevins, Lance K.
    Hueston, Linda
    Fraser, Robert J.
    Herrero, Lara J.
    Ramirez, Ruben
    Smith, Paul N.
    Mahalingam, Suresh
    Heise, Mark T.
    [J]. PLOS PATHOGENS, 2012, 8 (03)
  • [8] Hwang H, 2004, APPL IMMUNOHISTO M M, V12, P122
  • [9] Ko EC, 2001, AM J CLIN PATHOL, V116, P709
  • [10] Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals
    Kobal, Borut
    Noventa, Marco
    Cvjeticanin, Branko
    Barbic, Matija
    Meglic, Leon
    Herzog, Marusa
    Bordi, Giulia
    Vitagliano, Amerigo
    Saccardi, Carlo
    Skof, Erik
    [J]. RADIOLOGY AND ONCOLOGY, 2018, 52 (03) : 307 - 319